← Back to Search

2 for Post-Traumatic Stress Disorder (Hypnosis Trial)

N/A
Waitlist Available
Led By Tara Galovski, PhD
Research Sponsored by Center for Trauma Recovery, St Louis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Participants will be at least three months post-crime at the time of their participation and will have been diagnosed with PTSD. Participants will score at least a "3" on the CAPS symptom of sleep impairment. This score is indicative of clinically significant symptomatology on any PTSD symptom. There is no upper limit on time since the trauma for participation.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

Sleep impairment is the most often reported of the 17 PTSD symptoms and is considered one of the most refractory to treatment. This study proposes the use of sleep-directed hypnotherapy to address sleep issues as a complementary element to empirically supported Cognitive Processing Therapy (CPT) in treating PTSD in sexual and physical assault survivors. Specifically the study aims to: 1) compare the results of sleep-directed hypnosis plus CPT with CPT only, 2) to assess the relationship between sleep and PTSD symptoms, 3) to examine relationships between sleep improvement, PTSD symptom improvement, and the therapeutic elements (hypnosis, exposure, cognitive therapy) to determine mechanisms of action in the intervention, 4) to assess the relationship between sleep and physical reactivity to trauma-related cues and to other stimuli.

Eligible Conditions
  • Post-Traumatic Stress Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 2Experimental Treatment2 Interventions
Hypnosis plus Cognitive Processing Therapy.
Group II: 1Active Control1 Intervention
Cognitive Processing Therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Processing Therapy
2016
N/A
~4030
Hypnosis
2006
Completed Phase 4
~1300

Find a Location

Who is running the clinical trial?

Center for Trauma Recovery, St LouisLead Sponsor
1 Previous Clinical Trials
50 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
853 Previous Clinical Trials
671,690 Total Patients Enrolled
Tara Galovski, PhDPrincipal InvestigatorCenter for Trauma Recovery, University of Missouri- St. Louis
1 Previous Clinical Trials
50 Total Patients Enrolled
~3 spots leftby Nov 2025